Wegovy, as an injection, is FDA approved to: Reduce excess body weight and maintain long-term weight reduction in: Adults with obesity and adolescents ages 12 years and older with obesity Adults with overweight plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol Treat a serious type of fatty liver disease called noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver scarring (stage F2 to F3 fibrosis) Lower the risk of major cardiovascular problems (such as heart attack, stroke, and heart-related death) in adults with established cardiovascular disease and obesity or overweight Contrave is FDA approved to: Reduce excess body weight and maintain long-term weight reduction in: Adults with obesity, defined as a body mass index (BMI) of 30 or higher Adults with a BMI of 27 or higher (overweight) plus at least one weight-related medical condition To recap, heres an at-a-glance comparison of FDA-approved uses for Wegovy vs

These data underpin Zepbound's FDA approval for chronic weight management, but they do not automatically extend to Mounjaro coverage under TRICARE
Tapering off GLP-1 medication is often suggested as a way to make that transition phase feel more manageable
Also Phase three studies are underway for MASLD with these drugs
Gluten Free Lactose Free Vegan Directions: Adults: 1 Tablespoon daily (15 mL)
FAQs Is L-Carnitine good for weight loss